Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-06 01:50:43 - browse：7967

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter:

Novo Nordiskis conducting a large clinical trial to prove that its GLP-1 drug Wegovy, in addition to helping people lose weight, also improves cardiovascular health. The SELECT study enrolled 17,500 participants who had overweight or obesity and had preexisting heart disease. The participants were then randomized to receive weekly injections of Wegovy or a matching placebo. The primary goal is to determine the extent to which Wegovy reduces the risk of heart attacks, strokes, and heart-related deaths. Wegovy is already a blockbuster drug based on weight loss alone, but proving an additional cardiovascular benefit could open the commercial floodgates.

BridgeBiowill report in July an analysis of all-cause mortality from a clinical trial of its heart drug acoramidis. The outcome is an important, second attempt at demonstrating benefit for acoramidis in a progressive heart disease called ATTR-CM. In December 2021, the drug performed no better than a placebo on a test of how far study participants could walk over the course of six minutes, failing to achieve its primary goal. But in this second part of the same study, BridgeBio will determine if acoramidis can significantly reduce hospitalizations and death over the course of 30 months.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： A cyberattack has disrupted hospitals and health care in several states

knowledge

WSS

Will the market for weight loss drugs really reach $100 billion?

ReNAgade cuts staff seven months after raising $300 million

Disappointing trial forces Pfizer to pivot on obesity medicine plans

Fetal surgery at risk from Dobbs and new abortion restrictions

For BCIs, commercial hurdles may be bigger than scientific ones

A cyberattack has disrupted hospitals and health care in several states

entertainment

Wikipedia

leisure time

After affirmative action ruling, medical educators look to 'holistic review'

For BCIs, commercial hurdles may be bigger than scientific ones

Peter Hotez and the public health issue of online harassment

ER docs worry over extreme heat as a 'mass casualty event'

Psychedelics group wrestles with new pharma identity

UnitedHealth’s Optum accused of antitrust violations in California

Drug repurposing or repositioning? The language matters

ER docs worry over extreme heat as a 'mass casualty event'

Medicare details structure of new drug price negotiation program

The drug industry sees a key ally in the Senate prevail

leisure time

Humana, CVS hope to turn members into patients at clinics

Cigna, Humana reportedly in talks to merge

Organ aging and disease risk measured by new blood test

The drug industry sees a key ally in the Senate prevail

Will the market for weight loss drugs really reach $100 billion?

2 US Navy sailors arrested for allegedly spying for China

Wikipedia

knowledge

hotspot

leisure time